Novel |
AMFR |
autocrine motility factor receptor |
- N-glycan trimming in the ER and Calnexin/Calreticulin cycle
- ER Quality Control Compartment (ERQC)
|
|
|
Novel |
GOT2 |
glutamic-oxaloacetic transaminase 2 |
- Degradation of cysteine and homocysteine
- Glyoxylate metabolism and glycine degradation
- Gluconeogenesis
- Aspartate and asparagine metabolism
- Glutamate and glutamine metabolism
|
- Pyridoxal phosphate
- Aspartic acid
- Glutamic acid
- Cysteine
- 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
|
|
Novel |
ZNF423 |
zinc finger protein 423 |
|
|
- Systemic lupus erythematosus
|
|
ABCA1 |
ATP binding cassette subfamily A member 1 |
- PPARA activates gene expression
- Defective ABCA1 causes TGD
- HDL assembly
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
|
|
- Tangier disease
- Hypoalphalipoproteinemia
|
|
ACACA |
acetyl-CoA carboxylase alpha |
- ChREBP activates metabolic gene expression
- Biotin transport and metabolism
- Carnitine metabolism
- Activation of gene expression by SREBF (SREBP)
- Defective HLCS causes multiple carboxylase deficiency
- Fatty acyl-CoA biosynthesis
|
|
|
|
ADH1A |
alcohol dehydrogenase 1A (class I), alpha polypeptide |
- Abacavir metabolism
- RA biosynthesis pathway
- Ethanol oxidation
|
- NADH
- Fomepizole
- 4-Iodopyrazole
- N-Cyclopentyl-N-Cyclobutylformamide
|
|
|
AQP4 |
aquaporin 4 |
- Vasopressin regulates renal water homeostasis via Aquaporins
- Passive transport by Aquaporins
|
|
|
|
ARRB2 |
arrestin beta 2 |
- Activated NOTCH1 Transmits Signal to the Nucleus
- G alpha (s) signalling events
- Thrombin signalling through proteinase activated receptors (PARs)
- WNT5A-dependent internalization of FZD4
- Activation of SMO
- Activation of SMO
- MAP2K and MAPK activation
- Ub-specific processing proteases
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
|
|
|
|
ASL |
argininosuccinate lyase |
|
- Arginine
- Argininosuccinate
- 2-(N-morpholino)ethanesulfonic acid
|
- Argininosuccinic aciduria (ARGINSA); Argininosuccinate lyase deficiency
|
|
ATF1 |
activating transcription factor 1 |
- CREB phosphorylation
- NGF-stimulated transcription
- NGF-stimulated transcription
|
|
- Clear cell sarcoma of soft tissue
|
|
ATF2 |
activating transcription factor 2 |
- Transcriptional activation of mitochondrial biogenesis
- HATs acetylate histones
- Circadian Clock
- Activation of the AP-1 family of transcription factors
- TP53 Regulates Transcription of DNA Repair Genes
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Estrogen-dependent gene expression
- NGF-stimulated transcription
- NGF-stimulated transcription
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- Response of EIF2AK4 (GCN2) to amino acid deficiency
|
|
|
|
ATG16L1 |
autophagy related 16 like 1 |
- Macroautophagy
- Macroautophagy
|
|
|
|
BHLHE41 |
basic helix-loop-helix family member e41 |
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- Circadian Clock
|
|
|
|
BID |
BH3 interacting domain death agonist |
- Activation of BAD and translocation to mitochondria
- Activation and oligomerization of BAK protein
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- Activation, translocation and oligomerization of BAX
- TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
- Activation, myristolyation of BID and translocation to mitochondria
|
|
|
|
CABP1 |
calcium binding protein 1 |
|
|
|
|
CALM1 |
calmodulin 1 |
- CaMK IV-mediated phosphorylation of CREB
- CaMK IV-mediated phosphorylation of CREB
- Calmodulin induced events
- Cam-PDE 1 activation
- CaM pathway
- Platelet degranulation
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- PKA activation
- DARPP-32 events
- Synthesis of IP3 and IP4 in the cytosol
- Calcineurin activates NFAT
- Calcineurin activates NFAT
- eNOS activation
- Transcriptional activation of mitochondrial biogenesis
- Inactivation, recovery and regulation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- Stimuli-sensing channels
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Ca2+ pathway
- Reduction of cytosolic Ca++ levels
- Sodium/Calcium exchangers
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Smooth Muscle Contraction
- Smooth Muscle Contraction
- Activation of Ca-permeable Kainate Receptor
- Uptake and function of anthrax toxins
- VEGFR2 mediated vascular permeability
- VEGFR2 mediated cell proliferation
- Phase 0 - rapid depolarisation
- Ion homeostasis
- CLEC7A (Dectin-1) induces NFAT activation
- CLEC7A (Dectin-1) induces NFAT activation
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases activate PAKs
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Glycogen breakdown (glycogenolysis)
- Glycogen breakdown (glycogenolysis)
- Protein methylation
- Extra-nuclear estrogen signaling
- Loss of phosphorylation of MECP2 at T308
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Activation of RAC1 downstream of NMDARs
- Activation of RAC1 downstream of NMDARs
- Activation of AMPK downstream of NMDARs
- Long-term potentiation
- Long-term potentiation
- RAS processing
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated IL10 synthesis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Chlorpromazine
- Cinchocaine
- Nicardipine
- Fluphenazine
- Isoflurane
- Trifluoperazine
- Loperamide
- Perphenazine
- Phenoxybenzamine
- Felodipine
- Melatonin
- Promethazine
- Pimozide
- Nifedipine
- Bepridil
- Calcium
- Aprindine
- Deacetoxyvinzolidine
- tert-butanol
- Trimethyllysine
- N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
- Prenylamine
- Flunarizine
- (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
- Myristic acid
- Calcium citrate
- Calcium citrate
- Calcium citrate
- Calcium Phosphate
- Calcium Phosphate
- Calcium Phosphate
- Calcium levulinate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
|
|
|
CASQ2 |
calsequestrin 2 |
- Stimuli-sensing channels
- Ion homeostasis
|
- Calcium citrate
- Calcium Phosphate
- Calcium phosphate dihydrate
|
- Catecholaminergic polymorphic ventricular tachycardia
|
|
CAV1 |
caveolin 1 |
- Triglyceride catabolism
- eNOS activation
- NOSTRIN mediated eNOS trafficking
- Basigin interactions
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- VEGFR2 mediated vascular permeability
- Extra-nuclear estrogen signaling
- FOXO-mediated transcription of cell cycle genes
|
|
- Congenital generalized lipodystrophy (CGL)
|
|
CDC37 |
cell division cycle 37, HSP90 cochaperone |
- Signaling by ERBB2
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Constitutive Signaling by EGFRvIII
- Regulation of necroptotic cell death
- Downregulation of ERBB2 signaling
- RHOBTB2 GTPase cycle
- Constitutive Signaling by Overexpressed ERBB2
- Drug-mediated inhibition of ERBB2 signaling
- Signaling by ERBB2 KD Mutants
- Resistance of ERBB2 KD mutants to trastuzumab
- Resistance of ERBB2 KD mutants to sapitinib
- Resistance of ERBB2 KD mutants to tesevatinib
- Resistance of ERBB2 KD mutants to neratinib
- Resistance of ERBB2 KD mutants to osimertinib
- Resistance of ERBB2 KD mutants to afatinib
- Resistance of ERBB2 KD mutants to AEE788
- Resistance of ERBB2 KD mutants to lapatinib
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
- Drug resistance in ERBB2 TMD/JMD mutants
|
|
|
|
CLTB |
clathrin light chain B |
- Gap junction degradation
- Formation of annular gap junctions
- EPH-ephrin mediated repulsion of cells
- Lysosome Vesicle Biogenesis
- WNT5A-dependent internalization of FZD4
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
|
|
|